Differences in Ca2+ pumping activity between sub-populations of human red cells.

Cell Calcium

Instituto de Biología Experimental, Facultad de Ciencias, Universidad Central de Venezuela, Caracas, Venezuela.

Published: May 1997

It has been shown recently that the free Ca2+ content of human red cells rises during ageing in vivo. With the aim of determining the mechanisms involved in such a change, we have investigated some aspects of Ca2+ homeostasis. Both the initial rate of Ca2+ influx and some kinetic parameters of the Ca2+ pump of human red cells were studied in light and dense sub-populations obtained through stringent, self-formed Percoll gradients. At 37 degrees C and pH 7.4, no differences in Ca2+ entry were found. By contrast, either at pH 7.0 or 7.4, the maximal Ca2+ extrusion rate of the approximately 10% heaviest cells was one-half of the corresponding lighter ones. The results demonstrate that the elevated free Ca2+ concentration distinctive of senescent cells, arises from a reduction in Ca2+ extrusion capacity during ageing. The possible physiological significance of this finding is discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0143-4160(97)90028-2DOI Listing

Publication Analysis

Top Keywords

human red
12
red cells
12
differences ca2+
8
ca2+
8
free ca2+
8
ca2+ extrusion
8
cells
5
ca2+ pumping
4
pumping activity
4
activity sub-populations
4

Similar Publications

Hidden infections and late diagnoses are currently the main challenges of the HIV pandemic. Emergency departments (EDs) are one of the health care system's key resources addressing these challenges. In 2020, the Spanish Society of Emergency Medicine (SEMES) published recommendations for ordering HIV serology testing for patients with certain health conditions, and in 2021 SEMES launched the "Leave Your Mark" (Deja tu Huella - DTH) program to facilitate implementing the recommendations during emergency care.

View Article and Find Full Text PDF

Autoimmune hemolytic anemia (AIHA) is a condition that causes an individual's immune system to destroy its own red blood cells. Immune cells are activated against the red blood cell antigens to induce hemolysis. Patients typically present with symptomatic anemia when the extent of hemolysis overcomes the bone marrow's ability to compensate.

View Article and Find Full Text PDF

Scoping review of initiation criteria for inhaled nitric oxide in preterm infants (born <34 weeks) after 7 days of age.

BMJ Open

December 2024

Research and Development Center for New Medical Frontiers, Department of Advanced Medicine, Division of Neonatal Intensive Care Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

Objectives: Inhaled nitric oxide (iNO) is a known treatment for pulmonary hypertension (PH) associated with bronchopulmonary dysplasia in preterm infants after 7 days of age (postacute phase). However, a consensus regarding the optimal criteria for initiating iNO therapy in this population in the postacute phase is currently lacking. This study, therefore, aimed to identify the criteria for initiating iNO therapy, alongside the associated clinical and echocardiographic findings, in this population.

View Article and Find Full Text PDF

The discharge of oil-laden wastewater from industrial processes and the frequent occurrence of oil spills pose severe threats to the ecological environment and human health. Membrane materials with special wettability have garnered attention for their ability to achieve efficient oil-water separation by leveraging the differences in wettability at the oil-water interface. These materials are characterized by their simplicity, energy efficiency, environmental friendliness, and reusability.

View Article and Find Full Text PDF

RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington's disease models.

Mol Neurodegener

January 2025

Guangdong Key Laboratory of Non-Human Primate Research, Key Laboratory of CNS Regeneration (Ministry of Education), School of Medicine, GHM Institute of CNS Regeneration, Jinan University, Guangzhou, 510632, China.

Background: HD is a devastating neurodegenerative disorder caused by the expansion of CAG repeats in the HTT. Silencing the expression of mutated proteins is a therapeutic direction to rescue HD patients, and recent advances in gene editing technology such as CRISPR/CasRx have opened up new avenues for therapeutic intervention.

Methods: The CRISPR/CasRx system was employed to target human HTT exon 1, resulting in an efficient knockdown of HTT mRNA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!